MERTK receptor tyrosine kinase is a therapeutic target in melanoma.
Schlegel J; Sambade MJ; Sather S; Moschos SJ; Tan AC; Winges A; DeRyckere D; Carson CC; Trembath DG; Tentler JJ; Eckhardt SG; Kuan PF; Hamilton RL; Duncan LM; Miller CR; Nikolaishvili-Feinberg N; Midkiff BR; Liu J; Zhang W; Yang C; Wang X; Frye SV; Earp HS; Shields JM; Graham DK; The Journal Of Clinical Investigation, 2013, vol. 123, issue 5, p 2257, ISSN 15588238. ISBN 15588238.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef